<DOC>
	<DOC>NCT02602899</DOC>
	<brief_summary>Evaluate the long-term clinical effectiveness and safety of the PINS Deep Brain Stimulation to patients with refractory epilepsy.</brief_summary>
	<brief_title>Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Refractory Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<criteria>age 1260. having tried at least two appropriate antiepileptic drugs (AEDs) tested to tolerance or to blood levels at upper end of the target range of which at least 2 have been tolerated at normal dose. at least 6 seizures per month. in good health except epilepsy. to with normal MMSE score patients or his(her) familys could understand this method and sign the informed consent 7）Patients with good compliance and could complete postoperative followup results of MRI remind epilepsy caused by intracranial spaceoccupying lesions. the vagus nerve lesion and damage tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma，mental disease，peptic ulcer，diabetes Type 1，bad health etc, and other surgical contraindication.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>PINS</keyword>
	<keyword>Deep Brain Stimulator</keyword>
	<keyword>Refractory Epilepsy</keyword>
	<keyword>Anterior Thalamic Nucleus</keyword>
</DOC>